Tennessee Oncology, PLLC - Sarah Cannon (SCRI) — Nashville, Tennessee

Tennessee Oncology, PLLC - Sarah Cannon (SCRI) is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Tennessee Oncology, PLLC - Sarah Cannon (SCRI) has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumor, BRAF Gene Mutation, BRAF Gene Alteration.

Sponsors: BioMed Valley Discoveries, Inc.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology, PLLC - Sarah Cannon (SCRI)?

Tennessee Oncology, PLLC - Sarah Cannon (SCRI) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology, PLLC - Sarah Cannon (SCRI) conducted?

Tennessee Oncology, PLLC - Sarah Cannon (SCRI) has 1 clinical trials on record. Their work covers Advanced Solid Tumor, BRAF Gene Mutation, BRAF Gene Alteration.

Is Tennessee Oncology, PLLC - Sarah Cannon (SCRI) accredited by Crixeo Health?

Tennessee Oncology, PLLC - Sarah Cannon (SCRI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology, PLLC - Sarah Cannon (SCRI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.